News and Events

HKEX Goes High (Bio) Tech with Ascletis IPO
Duff & Phelps congratulates biotech firm Ascletis Pharma Inc. (1672.HK) on its initial public offering (IPO) on the Hong Kong Stock Exchange on August 1. Ascletis is the first pre-revenue biotech firm to launch in the wake of recent listing rule reforms that eased the threshold for such companies. Previous rules set by the Hong Kong Exchanges and Clearing (HKEX) required companies to possess minimum levels of either profitability or cashflow, excluding most pre-revenue biotech companies.

SFC Identifies Common Control Failings Observed during On-site Inspections in the Asset Management Industry
The Hong Kong Securities and Futures Commission (“SFC”) issued a circular on 15 September 2017 identifying regulatory concerns noted in the course of SFC’s supervision of licensed corporations (“LCs”) engaged in managing funds and discretionary accounts. 

Julian Korek Comments in GT News: How the Compliance Officer's Role is Changing
Julian Korek, Managing Director and Global Head of Compliance and Regulatory Consulting, was quoted in GT News, in an article discussing the changing role of the chief compliance officer within financial institutions.

Insights

Valuation Insights – Greater China Edition, August 2018
Valuation Insights is a quarterly e-newsletter that provides you with the latest news from Duff & Phelps and the trends and changes in valuation and accounting that could affect your business transactions in Asia

Global Ransomware Attack
The unprecedented global ransomware cyber-attack on May 12, 2017, dubbed by experts as Wanna Cry, Wanna Cryptor or Wanna Decryptor, exploits vulnerability in Microsoft Windows operating system to invisibly move from computer to computer.

Valuation Insights – Greater China Edition, April 2018
Valuation Insights is a quarterly e-newsletter that provides you with the latest news from Duff & Phelps and the trends and changes in valuation and accounting that could affect your business transactions in Asia